OptraSCAN Presents Automated Machine Learning-based Image Analysis for Programmed Death-Ligand 1 (PD-L1) Expression
San Jose, CA, October 23rd, 2018 — OptraSCAN®, the leading end-to-end digital pathology solution provider announced automated machine learning-based image analysis solution for Programmed Death Ligand 1 (PD-L1) expression. PD-L1 expression is an important cancer biomarker and has become a critical part of patient management for immunotherapy. The targeted blockade of PD-L1 may help to restore the anti-tumor response.
OptraSCAN’s Solution for Immuno-oncology
Optra PD-L1 automated image analysis for research use, supports interpretation of PD-L1 IHC expression on both tumor and immune cells in solid tumors. It determines PD-L1 expression on tumor and immune cells showing partial or complete membrane staining on tumor cells along with membrane and/or cytoplasmic staining on immune cells in a single read. It is reliable and can be used to assess PD- L1 expression in a more objective manner.
“Recent studies have shown that interpretation of PD-L1 IHC score is more reproducible for tumor cell staining, but not for immune cell staining. OptraSCAN’s AI & ML based analytics tool provides a possible approach in overcoming these challenges for assessment of programmed death-ligand 1 expression on tumor and immune cells in a more objective manner as an assisting tool for the pathologist,” said Dr. Anagha Jadhav, Director – Digital Pathology, OptraSCAN®.
General considerations by the PD-L1 assay:
- Fully automated solution for interpretation of PD-L1 IHC expression
- Score generation based on the number of PD-L1 positive cells in relation to total tumor and immune cells in a single read
- Computer aided region detection system for automated detection and evaluation of tumor nests and tumor infiltrating immune cells
About OptraSCAN®:
OptraSCAN® (www.optrascan.com) is an end-to-end digital pathology solution provider, focused on delivering fully integrated, affordable solutions that will maximize your return on investment and improve the performance of your pathology services. OptraSCAN® are pioneers in the On-Demand Digital Pathology® System and is working to eliminate the barriers to “Go Digital” no matter the size of the pathology lab, the lab’s throughput or global location.
OptraSCAN’s end-to-end solution provides effective acquisition of whole slide images, viewing, storing, sharing, reporting, analysis and management of digital slides and associated metadata, via On-Demand solution or outright purchase model. OptraSCAN is an ISO 13485 certified company and its whole slide scanners are CE marked for IVD use. Follow Us on LinkedIn and Twitter.
Contacts:
Media Inquiries:
Shruti Soman | Manager – Marketing Communications | 91.20.66540900 x 231 | s.soman@optraventures.com
Source: OptraSCAN®
